Our CEO, Emmet Browne, will be speaking at the Artificial Intelligence: Transforming Pharma R&D Congress in Boston, MA, USA on February 22nd. The two-day event brings together business leaders and innovators from the pharmaceutical industry to discuss how AI is being applied in industry today and will explore 7+ real life case studies demonstrating how AI is transforming pharma R&D.
As one of the innovative case studies at the event, we’re really looking forward to discussing how we are revolutionising pharma through the use of AI and genomics to discover health-benefiting bioactive peptides with extraordinary health benefits at a fraction of the time and cost compared to traditional drug discovery methods.
Session Title: Case Study: Exploring AI models to discover novel compounds and develop new drugs
What this presentation will explore:
-How Ai is being applied to discover compounds and how it is being used to develop drugs – based on peptides
-Using AI to data mine and discover peptide drug candidates
-Real life data and results to demonstrate the use of AI for a drug discovery project
Speaker: Emmet Browne, Nuritas CEO
Date: Thursday, February 22nd, 2018
Time: 11:00am EST
Location: Hilton Boston Dedham Hotel, 25 Allied Drive, Dedham, MA USA 02026
If you are heading to the event, get in touch: firstname.lastname@example.org
For more on this exciting event, click here.
Nuritas™, Emmet Browne